Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors

Center Eugene Marquis16 enrolled

Overview

For patient having a brain tumor, RMI is the standard exam for tumor characterization and determines initial surgery. The aim of this study is to assess if PET could provide additional information that could have an impact on surgery (indication and planification)

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Brain Neoplasms Adult Brain Tumor

Interventions

PET imageryDIAGNOSTIC_TEST

Every patients will have a PET imagery in addition to standard MRI

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Suspected glial resectable tumor * Free and informed consent * Affiliated to French social security Exclusion Criteria: * Suspected high grade glioma * Surgical emergency * Pregnant or breastfeeding woman * Patient deprived of their liberty or under guardianship * Patient not able to follow study medical monitoring for geographical, social or psychological reasons * Treated with carbidopa, catechol-O-methyl transferase inhibitor, haloperidol, reserpine within 2 weeks before PET imagery

Locations (1)

Centre Eugène Marquis

Rennes, Brittany Region, France

Outcomes

Primary Outcomes

PET pictures and MRI sequences comparison

Comparison of PET pictures and MRI sequences will be done in order to assess concordance between both imagings

Time frame: Imagings performed up to 29 days after inclusion (before brain surgery)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.